As of September 2024, Apex Biotechnology has a market cap of $92.57M. This makes Apex Biotechnology the world's 21667th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $105.86M | -16.00% |
2023 | $126.04M | 57.73% |
2022 | $79.91M | -1.73% |
2021 | $81.31M | 9.70% |
2020 | $74.12M | -16.40% |
2019 | $88.66M | -4.55% |
2018 | $92.89M | -6.90% |
2017 | $99.77M | -22.76% |
2016 | $129.16M | -12.13% |
2015 | $146.99M | -19.52% |
2014 | $182.64M | -14.12% |
2013 | $212.67M | -9.33% |
2012 | $234.56M | 24.56% |
2011 | $188.31M | -11.95% |
2010 | $213.88M | 7.36% |
2009 | $199.22M | 53.90% |
2008 | $129.45M | -34.14% |
2007 | $196.55M | 85.03% |
2006 | $106.22M | 79.00% |
2005 | $59.34M | 14.22% |
2004 | $51.96M | -37.86% |
2003 | $83.61M | -10.68% |
2002 | $93.60M | -28.61% |
2001 | $131.11M | 3.29% |
2000 | $126.93M | - |